3 results
Approved WMOCompleted
To investigate whether treatment with sulodexide can reverse postprandial dyslipidemia in patients with type 2 diabetes mellitus
Approved WMOPending
To compare EFS of participants in the primary analysis population with Stage II-IIIA RET fusion-positive NSCLC treated with selpercatinib versus placebo.
Approved WMOPending
To assess the efficacy of treatment with sulodexide for chronic heart failure.